GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syndax Pharmaceuticals Inc (STU:1T3) » Definitions » Institutional Ownership

Syndax Pharmaceuticals (STU:1T3) Institutional Ownership : 46.02% (As of Jun. 20, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Syndax Pharmaceuticals Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Syndax Pharmaceuticals's institutional ownership is 46.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Syndax Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Syndax Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 99.18%.

Syndax Pharmaceuticals Institutional Ownership Historical Data

The historical data trend for Syndax Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syndax Pharmaceuticals Institutional Ownership Chart

Syndax Pharmaceuticals Historical Data

The historical data trend for Syndax Pharmaceuticals can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 45.05 44.49 40.70 40.54 42.46 42.74 42.92 46.55 45.80 46.02

Syndax Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Syndax Pharmaceuticals (STU:1T3) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syndax Pharmaceuticals Inc (STU:1T3) » Definitions » Institutional Ownership
Comparable Companies
IOVA MRVI LGND NWBO VKTX VTYX TNGX APGE REPL MORF OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
SNDX:USA
Address
35 Gatehouse Drive, Building D, Floor 3, Waltham, MA, USA, 02451
Website
https://www.syndax.com
Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

Syndax Pharmaceuticals (STU:1T3) Headlines

No Headlines